Skip Nav Destination
Issues
15 January 2018
-
Cover Image
Cover Image
The cover shows a section of the lung from a patient affected by adenocarcinoma. Double immunofluorescence staining illustrating cytotoxic tumor-infiltrating lymphocytes (TIL) carrying granzyme B (green) to hinder the invasion of the bronchial lumen by cytokeratin positive (red) cancer cells. For details, see the article by Mazzaschi and colleagues on page 407 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Reviews
Cancer Therapy: Clinical
Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy
Matthew P. Morrow; Kimberly A. Kraynyak; Albert J. Sylvester; Michael Dallas; Dawson Knoblock; Jean D. Boyer; Jian Yan; Russell Vang; Amir S. Khan; Laurent Humeau; Niranjan Y. Sardesai; J. Joseph Kim; Stanley Plotkin; David B. Weiner; Cornelia L. Trimble; Mark L. Bagarazzi
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma
Sara A. Byron; Nhan L. Tran; Rebecca F. Halperin; Joanna J. Phillips; John G. Kuhn; John F. de Groot; Howard Colman; Keith L. Ligon; Patrick Y. Wen; Timothy F. Cloughesy; Ingo K. Mellinghoff; Nicholas A. Butowski; Jennie W. Taylor; Jennifer L. Clarke; Susan M. Chang; Mitchel S. Berger; Annette M. Molinaro; Gerald M. Maggiora; Sen Peng; Sara Nasser; Winnie S. Liang; Jeffrey M. Trent; Michael E. Berens; John D. Carpten; David W. Craig; Michael D. Prados
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
Channing J. Paller; Xian C. Zhou; Elisabeth I. Heath; Mary-Ellen Taplin; Tina Mayer; Mark N. Stein; Glenn J. Bubley; Roberto Pili; Tamaro Hudson; Radhika Kakarla; Muneer M. Abbas; Nicole M. Anders; Donna Dowling; Serina King; Ashley B. Bruns; William D. Wagner; Charles G. Drake; Emmanuel S. Antonarakis; Mario A. Eisenberger; Samuel R. Denmeade; Michelle A. Rudek; Gary L. Rosner; Michael A. Carducci
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer
Axel Grothey; Jonathan R. Strosberg; Lindsay A. Renfro; Herbert I. Hurwitz; John L. Marshall; Howard Safran; Michael J. Guarino; George P. Kim; J.R. Hecht; Susan C. Weil; John Heyburn; Wenquan Wang; Charles Schweizer; Daniel J. O'Shannessy; Luis Alberto Diaz, Jr
Personalized Medicine and Imaging
Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer
S. Intidhar Labidi-Galy; Timothée Olivier; Manuel Rodrigues; Domenico Ferraioli; Olfa Derbel; Alexandre Bodmer; Patrick Petignat; Beata Rak; Nicolas Chopin; Olivier Tredan; Pierre-Etienne Heudel; Sarah Stuckelberger; Pierre Meeus; Patrick Meraldi; Valeria Viassolo; Aurélie Ayme; Pierre O. Chappuis; Marc-Henri Stern; Claude Houdayer; Dominique Stoppa-Lyonnet; Adrien Buisson; Lisa Golmard; Valérie Bonadona; Isabelle Ray-Coquard
Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non–Small Cell Lung Cancer
Kathryn C. Arbour; Emmett Jordan; Hyunjae Ryan Kim; Jordan Dienstag; Helena A. Yu; Francisco Sanchez-Vega; Piro Lito; Michael Berger; David B. Solit; Matthew Hellmann; Mark G. Kris; Charles M. Rudin; Ai Ni; Maria Arcila; Marc Ladanyi; Gregory J. Riely
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer
Yifan Wang; Jayanthi Gudikote; Uma Giri; Jun Yan; Weiye Deng; Rui Ye; Wen Jiang; Nan Li; Brian P. Hobbs; Jing Wang; Stephen G. Swisher; Junya Fujimoto; Ignacio I. Wistuba; Ritsuko Komaki; John V. Heymach; Steven H. Lin
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response
Alexander Muckenhuber; Anne Katrin Berger; Anna Melissa Schlitter; Katja Steiger; Björn Konukiewitz; Andreas Trumpp; Roland Eils; Jens Werner; Helmut Friess; Irene Esposito; Günter Klöppel; Güralp O. Ceyhan; Moritz Jesinghaus; Carsten Denkert; Marcus Bahra; Albrecht Stenzinger; Martin R. Sprick; Dirk Jäger; Christoph Springfeld; Wilko Weichert
Cancer Therapy: Preclinical
Author Choice
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression
Timothy L. Lochmann; Konstantinos V. Floros; Mitra Naseri; Krista M. Powell; Wade Cook; Ryan J. March; Giovanna T. Stein; Patricia Greninger; Yuki Kato Maves; Laura R. Saunders; Scott J. Dylla; Carlotta Costa; Sosipatros A. Boikos; Joel D. Leverson; Andrew J. Souers; Geoffrey W. Krystal; Hisashi Harada; Cyril H. Benes; Anthony C. Faber
Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
JongBok Lee; Mark D. Minden; Weihsu C. Chen; Elena Streck; Branson Chen; Hyeonjeong Kang; Andrea Arruda; Dalam Ly; Sandy D. Der; Sohyeong Kang; Paulina Achita; Cheryl D'Souza; Yueyang Li; Richard W. Childs; John E. Dick; Li Zhang
Author Choice
Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
Pei-Yin Hsu; Victoria Shang Wu; Noriko Kanaya; Karineh Petrossian; Hang-Kai Hsu; Duc Nguyen; Daniel Schmolze; Masaya Kai; Chun-Yu Liu; Hannah Lu; Peiguo Chu; Courtney A. Vito; Laura Kruper; Joanne Mortimer; Shiuan Chen
Biology of Human Tumors
Author Choice
Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value
Giulia Mazzaschi; Denise Madeddu; Angela Falco; Giovanni Bocchialini; Matteo Goldoni; Francesco Sogni; Giovanna Armani; Costanza Annamaria Lagrasta; Bruno Lorusso; Chiara Mangiaracina; Rocchina Vilella; Caterina Frati; Roberta Alfieri; Luca Ampollini; Michele Veneziani; Enrico Maria Silini; Andrea Ardizzoni; Konrad Urbanek; Franco Aversa; Federico Quaini; Marcello Tiseo
Author Choice
Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell–Cancer-Associated Fibroblast Interactions during Collective Invasion
Alessandra M. Richardson; Lauren S. Havel; Allyson E. Koyen; Jessica M. Konen; John Shupe; W.G. Wiles, IV; W. David Martin; Hans E. Grossniklaus; Gabriel Sica; Melissa Gilbert-Ross; Adam I. Marcus
Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy
Qinghai Zeng; Jianye Liu; Peiguo Cao; Jingjing Li; Xiaoming Liu; Xiaojun Fan; Ling Liu; Yan Cheng; Wei Xiong; Jigang Li; Hao Bo; Yuxing Zhu; Fei Yang; Jun Hu; Ming Zhou; Yanhong Zhou; Qiong Zou; Jianda Zhou; Ke Cao
Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma
Ling Tang; Jun Zeng; Pengyu Geng; Chengnan Fang; Yang Wang; Mingju Sun; Changsong Wang; Jiao Wang; Peiyuan Yin; Chunxiu Hu; Lei Guo; Jane Yu; Peng Gao; Enyou Li; Zhengping Zhuang; Guowang Xu; Yang Liu
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds